Search Results - "Córdoba, Iris"

Real World Treatment Outcomes of Patients with Acute Lymphoblastic Leukemia Treated with the PETHEMA ALLHR11 Protocol, Emphasis on Minimal Residual Disease and Survival by Camargo, Carmenza, Herrera, Maria Victoria, Solano-Vega, Julio, Rojas, Silvia Margarita, Córdoba, Iris, Heider, Ulrike, Parra, Norma, Sanchez, Paula, Arévalo, Diego, Sandoval, Gisella, Muñoz, Stephanía, Arévalo-Zambrano, Mónica

Get full text

Características clínicas y microbiológicas de pacientes con neutropenia febril en un hospital Universitario by Garzón, Javier Ricardo, Isaza1, Nicolas, Posada1, Adriana, Mendez1, Rafael, Arenas1, Juliana, Ardila1, Maria Paula, Cardenas, Felipe, Barrera, Viviana, Moreno, Paula, Córdoba, Iris, Rodríguez, Maria Nelcy

“…Resumen Objetivo: Describir las características clínicas, demográficas, frecuencia, tipo de aislamientos microbiológicos y resistencia a los antimicrobianos de…”
Get full text

No-Myeloablative Conditioning Regimen Cyclosphophamide-Fludarabine-ATG (Cy-Flu-ATG) Results in Better Overall Survival Compared with Myeloablative Doses of Cy with or without ATG, in High-Risk Bone Marrow Failure Syndromes (BMFS) Patients by Abello, Virginina, MD, Villamizar, Licet, MsC, Pedraza, Enrique, MD, Esguerra, Herman, MD, Rosales, Carmen, MD, Rosales, Manuel, MD, Figueroa, Javier, MD, Cordoba, Iris, MD, Linares, Adriana

Get full text

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome (MDS): A Single Center Experience by Abello, Virginina, MD, Villamizar, Licet, MsC, Pedraza, Enrique, MD, Rosales, Carmen, MD, Rosales, Manuel, MD, Figueroa, Javier, MD, Cordoba, Iris, MD, Esguerra, Herman, MD

Get full text

Allogeneic Match Unrelated DONOR Trasplantation: First Experience in Colombia by Abello, Virginina, MD, Villamizar, Licet, MsC, Pedraza, Enrique, MD, Esguerra, Herman, MD, Rosales, Carmen, MD, Rosales, Manuel, MD, Figueroa, Javier, MD, Cordoba, Iris, MD

Get full text

Prognostic Impact of Pretransplantation Minimal Residual Disease Detection for Flow Cytometric, on Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia. a Single Center Experience in Colombia over 14 Years by Borda Molina, Andres Armando, Cordoba, Iris, Abello, Virginia, Rosales, Carmen, Manuel, Rosales, Figueroa, Javier, Villegas, Adriana, Osuna, Monica, Pedraza, Enrique

“…Background: The accumulated evidence from studies of multiparameter flow cytometric MRD (MFC-MRD) assessment in AML leaves little doubt that this method of MRD…”
Get full text

Validation of the EBMT Risk Score for Patients with Hematologic Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplant in a Transplant Center in Colombia over 20 Years by Abello, Virginia, Rosales, Carmen, Rosales, Manuel, Figueroa, Javier, Cordoba, Iris, Borda Molina, Andres Armando, Pedraza, Enrique, Esguerra, Herman, Villamizar, Liceth

“…INTRODUCCION EMBT the risk score has been validated in several studies in different types of diseases and modalities of transplantation. The conditions of the…”
Get full text

Related or Unrelated Donor Results in Similar Outcomes after Hsct; Single Center Experience in Colombia by Abello, Virginia, Rosales, Carmen, Rosales, Manuel, Figueroa, Javier, Cordoba, Iris, Borda Molina, Andres Armando, Pedraza, Enrique, Esguerra, Herman, Villamizar, Liceth

“…INTRODUCTION ASTC is the standard treatment in multiple hematologic diseases; unfortunately most patients do not have a compatible family donor, URD ASCT is an…”
Get full text

Prognostic impact of severe thrombocytopenia in low‐risk myelodysplastic syndrome by Gonzalez‐Porras, Jose Ramon, Cordoba, Iris, Such, Esperanza, Nomdedeu, Benet, Vallespi, Teresa, Carbonell, Felix, Luño, Elisa, Ardanaz, Maite, Ramos, Fernando, Pedro, Carme, Gomez, Valle, de Paz, Raquel, Sanchez‐Barba, Mercedes, Sanz, Guillermo F., del Cañizo, and Consuelo

“…BACKGROUND: Thrombocytopenia is very common in myelodysplastic syndrome (MDS); however, its clinical impact in low‐risk patients remains controversial…”
Get full text

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome by Cordoba, Iris, González‐Porras, José R., Nomdedeu, Benet, Luño, Elisa, de Paz, Raquel, Such, Esperanza, Tormo, Mar, Vallespi, Teresa, Collado, Rosa, Xicoy, Blanca, Andreu, Rafael, Muñoz, Juan A., Solé, Francesc, Cervera, Jose, del Cañizo, Consuelo

“…BACKGROUND: Abnormalities involving chromosome 7 are frequent in myelodysplastic syndrome (MDS) and suggest a poor prognosis. METHODS: The authors examined the…”
Get full text

Risk of placenta‐mediated pregnancy complications or pregnancy‐related VTE in VTE ‐asymptomatic families of probands with VTE and heterozygosity for factor V L eiden or G 20210 prothrombin mutation by Cordoba, Iris, Pegenaute, Carlota, González‐López, Tomás José, Chillon, Carmen, Sarasquete, Maria Eugenia, Martin‐Herrero, Francisco, Guerrero, Carmen, Cabrero, Mónica, Garcia Sanchez, Maria Helena, Pabon, Pedro, Lozano, Francisco Santiago, Gonzalez, Marcos, Alberca, Ignacio, González‐Porras, José Ramón

“…Abstract Background Few studies have evaluated the risk of pregnancy‐related adverse events in asymptomatic relatives of probands for VTE and factor V Leiden…”
Get full text

Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation by Cordoba, Iris, Pegenaute, Carlota, González-López, Tomás José, Chillon, Carmen, Sarasquete, Maria Eugenia, Martin-Herrero, Francisco, Guerrero, Carmen, Cabrero, Mónica, Garcia Sanchez, Maria Helena, Pabon, Pedro, Lozano, Francisco Santiago, Gonzalez, Marcos, Alberca, Ignacio, González-Porras, José Ramón

“…Background Few studies have evaluated the risk of pregnancy‐related adverse events in asymptomatic relatives of probands for VTE and factor V Leiden or the…”
Get full text